Physician profile
Anil Om
NPI 1972560332
$20,876.51
in general payments reported to CMS, 2019-2025
45 companies · $2,204 in 2025
The $2,204 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,253 · 2020: $2,404 · 2021: $7,326 · 2022: $3,644 · 2023: $1,838 · 2024: $2,207 · 2025: $2,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,899 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,898.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $10,191.09 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Janssen Pharmaceuticals, INC | $2,369.31 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $982.07 | 2019-2025 | |
| Boston Scientific Corporation | $535.96 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $518.11 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $434.50 | 2019-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $425.12 | 2019-2025 | Lifevest |
| Medtronic, INC. | $407.08 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Chiesi USA, INC. | $406.17 | 2019-2025 | Kengreal, Cleviprex |
| Pfizer INC. | $403.99 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $393.50 | 2021-2025 | Verquvo, Capvaxive |
| Abbott Laboratories | $363.91 | 2022-2025 | Pressurewire, Diamondback Coronary, Xience Skypoint |
| Boehringer Ingelheim Pharmaceuticals, INC. | $319.02 | 2020-2025 | Jardiance |
| Novo Nordisk INC | $280.51 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Shockwave Medical, INC | $279.78 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $278.75 | 2021-2025 | Nexletol |
| Vital Connect, INC | $239.85 | 2024 | Vitalpatch Rtm |
| Cvrx, INC. | $235.01 | 2023-2025 | Barostim Neo System |
| Biotronik INC. | $204.96 | 2020-2023 | Biomonitor, Renamic Neo |
| Inari Medical, INC. | $174.22 | 2021-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amarin Pharma, INC. | $140.07 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $132.38 | 2019-2023 | |
| Abiomed | $125.25 | 2022-2025 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $122.47 | 2024-2025 | |
| Medtronic Vascular, INC. | $116.47 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $104.16 | 2024-2025 | Onpattro, Amvuttra |
| Ferring Pharmaceuticals INC. | $97.65 | 2025 | Rebyota |
| Impulse Dynamics (USA) INC. | $93.26 | 2025 | Optimizer |
| Regeneron Healthcare Solutions, INC. | $54.00 | 2019-2020 | |
| Gilead Sciences, INC. | $48.20 | 2019 | |
| Bridgebio Pharma, INC. | $47.39 | 2025 | Attruby |
| Daiichi Sankyo INC. | $45.33 | 2022-2025 | Injectafer |
| Lexicon Pharmaceuticals, INC. | $32.71 | 2023 | Inpefa |
| Philips North America LLC | $28.97 | 2023 | |
| Atricure, INC. | $28.70 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Kiniksa Pharmaceuticals International, Plc | $26.11 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $25.31 | 2024 | Inspire |
| Actelion Pharmaceuticals US, INC. | $25.00 | 2019 | |
| Corcept Therapeutics | $24.68 | 2025 | Korlym |
| Angiodynamics, INC. | $23.67 | 2025 | Alphavac |
| Ge Healthcare | $22.92 | 2020-2021 | |
| Scpharmaceuticals INC. | $22.77 | 2025 | |
| Astellas Pharma US INC | $16.76 | 2020 | |
| Lilly USA, LLC | $16.09 | 2025 | Mounjaro, Zepbound |
| Portola Pharmaceuticals, LLC | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Om listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.